You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報27,801點 跌161點; 恆生科技指數半日收報7,688點 升28點 藥明生物升逾7% 兗煤、康寧傑瑞製藥、金斯瑞生物科技創新高
恆指半日收27,801點,跌161點或0.6%。恆生科技指數報7,688點,升28點或0.4%。國指跌44點或0.4%,報10,068點。

活躍重磅股表現:

平安(02318.HK) 收70元,下跌2.7%;

美團(03690.HK) 收289.4元,下跌1.9%;

建行(00939.HK) 收5.47元,下跌1.4%;

騰訊(00700.HK) 收562元,上升1.2%;

阿裏巴巴(09988.HK) 收206元,上升0.4%;

港交所(00388.HK) 收506元,無升跌;

異動恆指及國指成份股:

藥明生物(02269.HK) 收141.1元,上升7.5%;

中國飛鶴(06186.HK) 收17元,上升6.9%;

比亞迪(01211.HK) 收222.8元,下跌4.9%;

石藥(01093.HK) 收10.98元,上升4.4%;

信義光能(00968.HK) 收15.62元,下跌4.3%;

申洲(02313.HK) 收172.9元,下跌3.6%;

中生製藥(01177.HK) 收7.27元,上升3.4%;

中國恆大(03333.HK) 收8.99元,下跌3.1%;

農夫山泉(09633.HK) 收44.8元,上升3.1%;

華潤啤酒(00291.HK) 收68.25元,上升3%;

異動綜合中小型股:

四環醫藥(00460.HK) 收3.11元,上升13.1%;

兗煤(01171.HK) 收11.68元,上升8.1%,創新高;

康寧傑瑞製藥(09966.HK) 收28元,上升7.7%,創新高;

金斯瑞生物科技(01548.HK) 收39.95元,上升6.5%,創新高;

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account